M. Godfried, T. Van-der-poll, and G. Weverling, Soluble Receptors for Tumor Necrosis Factor as Predictors of Progression to AIDS in Asymptomatic Human Immunodeficiency Virus Type 1 Infection, Journal of Infectious Diseases, vol.169, issue.4, pp.739-745, 1994.
DOI : 10.1093/infdis/169.4.739

M. Godfried, T. Van-der-poll, and J. Mulder, Soluble Tumor Necrosis Factor Receptors as Surrogate Markers for the Assessment of Zidovudine Treatment in Asymptomatic HIV-1 Infection, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.10, issue.5, pp.531-539, 1995.
DOI : 10.1097/00042560-199510050-00006

J. Fahey, J. Taylor, and R. Detels, The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1, New England Journal of Medicine, vol.322, issue.3, pp.166-172, 1990.
DOI : 10.1056/NEJM199001183220305

R. Zangerle, S. Steinhuber, and M. Sarcletti, Serum HIV???1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV???1???Infected Individuals, International Archives of Allergy and Immunology, vol.116, issue.3, pp.228-239, 1998.
DOI : 10.1159/000023949

P. Aukrust, F. Muller, and E. Lien, Tumor Necrosis Factor (TNF) System Levels in Human Immunodeficiency Virus???Infected Patients during Highly Active Antiretroviral Therapy: Persistent TNF Activation Is Associated with Virologic and Immunologic Treatment Failure, The Journal of Infectious Diseases, vol.179, issue.1, pp.74-82, 1999.
DOI : 10.1086/314572

M. Saves, P. Morlat, and G. Chene, Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy, Clinical Immunology, vol.99, issue.3, pp.347-352, 2001.
DOI : 10.1006/clim.2001.5033

D. Stein, R. Lyles, and N. Graham, Predicting Clinical Progression or Death in Subjects with Early???Stage Human Immunodeficiency Virus (HIV) Infection: A Comparative Analysis of Quantification of HIV RNA, Soluble Tumor Necrosis Factor Type II Receptors, Neopterin, and $\beta _{2}$ -Microglobulin, The Journal of Infectious Diseases, vol.176, issue.5, pp.1161-1167, 1997.
DOI : 10.1086/514108

F. Bonnet, M. Saves, and P. Morlat, Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART

S. Prescott, G. Zimmerman, and T. Mcintyre, Platelet-activating factor, J Biol Chem, vol.268, pp.17381-17384, 1996.

V. Kravchenko, Z. Pan, J. Han, J. Herbert, R. Ulevitch et al., Platelet-activating Factor Induces NF-??B Activation through a G Protein-coupled Pathway, Journal of Biological Chemistry, vol.270, issue.25, pp.14928-14934, 1995.
DOI : 10.1074/jbc.270.25.14928

L. Naour, R. Clayette, P. Henin, and Y. , Infection of human macrophages with an endogenous tumour necrosis factor-?? (TNF-??)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-?? synthesis inhibitor RP 55778, Journal of General Virology, vol.75, issue.6, pp.1379-1388, 1994.
DOI : 10.1099/0022-1317-75-6-1379

M. Nakamura, Z. Honda, and T. Izumi, Molecular cloning and expression of platelet-activating factor receptor from human leukocytes, J Biol Chem, vol.266, pp.20400-20405, 1991.

L. Tjoelker and D. Stafforini, Platelet-activating factor acetylhydrolases in health and disease, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1488, issue.1-2, pp.102-123, 2000.
DOI : 10.1016/S1388-1981(00)00114-1

P. Pietarinen-runtti, E. Lakari, K. Raivio, and V. Kinnula, Expression of antioxidant enzymes in human inflammatory cells, Am J Physiol Cell Physiol, vol.278, pp.118-125, 2000.

L. Herzenberg, D. Rosa, S. Dubs, and J. , Glutathione deficiency is associated with impaired survival in HIV disease, Proceedings of the National Academy of Sciences, vol.94, issue.5, pp.1967-1972, 1997.
DOI : 10.1073/pnas.94.5.1967

E. Garaci, A. Palamara, and M. Ciriolo, Intracellular GSH content and HIV replication in human macrophages, J Leukoc Biol, vol.62, pp.54-59, 1997.

F. Staal, M. Roederer, and L. Herzenberg, Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus., Proceedings of the National Academy of Sciences, vol.87, issue.24, pp.9943-9947, 1990.
DOI : 10.1073/pnas.87.24.9943

L. Moing, V. Thiébaut, R. Chêne, and G. , Plasma HIV RNA as predictor of long-term increase of CD4 cell counts in human immunodeficiency virus-infected patients initiating a protease-inhibitor containing regimen, J Infect Dis, vol.185, pp.471-480, 2002.

D. Centers and . Control, Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR Morb Mortal Wkly Rep, vol.41, pp.1-19, 1992.

M. Hughes, V. Johnson, and M. Hirsch, Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response, Annals of Internal Medicine, vol.126, issue.12, pp.929-938, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00001

J. Mellors, A. Munoz, and J. Giorgi, Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-954, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003

N. Graham, The role of immunologic and viral markers in predicting clinical outcome in HIV infection, AIDS, vol.10, pp.21-25, 1996.
DOI : 10.1097/00002030-199612005-00004

I. Engelberts, A. Moller, G. Schoen, C. Van-der-linden, and W. Buurman, Evaluation of measurement of human TNF in plasma by ELISA, Lymphok Cytok Res, vol.10, pp.69-76, 1991.

D. Aderka, H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach, Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, Journal of Experimental Medicine, vol.175, issue.2, pp.323-329, 1992.
DOI : 10.1084/jem.175.2.323

A. Kalinkovich, R. Geleziunas, and O. Kemper, Increased Soluble Tumor Necrosis Factor Receptor Expression and Release by Human Immunodeficiency Virus Type 1 Infection, Journal of Interferon & Cytokine Research, vol.15, issue.9, pp.749-757, 1995.
DOI : 10.1089/jir.1995.15.749

J. Benito, M. Lopez, S. Lozano, P. Martinez, J. Gonzales-lahoz et al., CD38 Expression on CD8 T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy, AIDS Research and Human Retroviruses, vol.20, issue.2, pp.227-233, 2004.
DOI : 10.1089/088922204773004950

P. Ondoa, S. Koblavi-dème, M. Borget, M. Nolan, J. Nkengasong et al., Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire, Clinical and Experimental Immunology, vol.5, issue.1, pp.138-148, 2005.
DOI : 10.1159/000069339

A. Steel, L. John, and M. Shamji, CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy, HIV Medicine, vol.18, issue.2, pp.118-125, 2008.
DOI : 10.1038/nm1511

C. Wang, T. Wen, J. Routy, N. Bernard, R. Sekaly et al., 4-1BBL Induces TNF Receptor-Associated Factor 1-Dependent Bim Modulation in Human T Cells and Is a Critical Component in the Costimulation-Dependent Rescue of Functionally Impaired HIV-Specific CD8 T Cells, The Journal of Immunology, vol.179, issue.12, pp.8252-8263, 2007.
DOI : 10.4049/jimmunol.179.12.8252

G. Herbein and K. Khan, Is HIV infection a TNF receptor signalling-driven disease?, Trends in Immunology, vol.29, issue.2, pp.61-67, 2008.
DOI : 10.1016/j.it.2007.10.008

URL : https://hal.archives-ouvertes.fr/hal-00464761

A. Pérez-casanova, K. Husain, R. Noel, . Jr, V. Rivera-amill et al., Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque, Molecular and Cellular Biochemistry, vol.63, issue.1-2, pp.169-175, 2008.
DOI : 10.1007/s11010-007-9625-0

R. Jariwalla, J. Lalezari, D. Cenko, S. Mansour, A. Kumar et al., -Lipoic Acid Supplementation in Patients with HIV Infection, The Journal of Alternative and Complementary Medicine, vol.14, issue.2, pp.139-146, 2008.
DOI : 10.1089/acm.2006.6397

C. Stephensen, G. Marquis, S. Douglas, L. Kruzich, and C. Wilson, Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults, Am J Clin Nutr, vol.85, pp.173-181, 2007.

J. Merrill, Y. Koyanagi, and C. Is, Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor, J Virol, vol.63, pp.4404-4408, 1989.

J. Merrill, Y. Koyanagi, J. Zack, L. Thomas, F. Martin et al., Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1, J Virol, vol.66, pp.2217-2225, 1992.

M. Westendorp, V. Shatrov, and K. Schulze-osthoff, HIV- 1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state, EMBO J, vol.14, pp.546-554, 1995.

K. Kedzierska and S. Crowe, Cytokines and HIV-1: Interactions and Clinical Implications, Antiviral Chemistry and Chemotherapy, vol.11, issue.3, pp.133-150, 2001.
DOI : 10.1038/382829a0

L. Maestra, L. Zaninoni, A. Marriott, J. Lazzarin, A. Dalgleish et al., The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro, Clinical and Experimental Immunology, vol.4, issue.1, pp.123-129, 2000.
DOI : 10.1073/pnas.95.15.8869

J. Jacobson, J. Greenspan, and J. Spritzler, Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.336, issue.21, pp.1487-1493, 1997.
DOI : 10.1056/NEJM199705223362103

A. Wanchu, A. Bhatnagar, and P. Bambery, Prevention of opportunistic infections in HIV infection by pentoxyphylline, Indian J Med Res, vol.124, pp.705-708, 2006.

L. Kuller and S. Study, Elevated levels of interleukin- 6 and D-dimer are associated with an increased risk of death in patents with HIV, 15th Conference on Retroviruses and Opportunistic Infections, 2008.

J. Salazar-gonzalez, O. Martinez-maza, and N. Aziz, Relationship of Plasma HIV-RNA Levels and Levels of TNF-?? and Immune Activation Products in HIV Infection, Clinical Immunology and Immunopathology, vol.84, issue.1, pp.36-45, 1997.
DOI : 10.1006/clin.1997.4364